Biden Judge Puts Women’s Lives at Risk by Ruling Against FDA Abortion Pill Regulations

Last week, on July 23, U.S. District Court Judge Robert Ballou, based in Virginia ruled that 2023 Food and Drug Administration restrictions on the distribution of the abortion causing drug Mifepristone did not meet required review standards and therefor the restrictions were not justified.“The 2023 REMS modification is unlawful and must be remanded to the FDA for review,” Ballou wrote, using the acronym for the FDA’s Risk Evaluation and Mitigation Strategies protocols.Abortion businesses have lo